Sorrento Therapeutics Inc (SRNE)

[dia76ca]

Many people wonder why Sorrento is meeting delays from the FDA. The FDA has the important job of seeing that drugs are both safe and effective. But why do big companies like Abbott get rapid approval on very inaccurate test kits while Sorrento seems to struggle to advance superior tests? And the recent approval of Biogen's questionable Alzheimer drug against the advice of a panel of experts has shaken the confidence in the FDA's fairness.
Meanwhile Sorrento is providing more and more advanced technologies and will progress in Latin America, Europe and perhaps India...to meet the ongoing worldwide Covid crisis. Hopefully the FDA will catch up soon.